Breaking: Federal Judge Grants Lilly’s Motion to Halt 340B Dispute Resolution System

In a decision that could have significant implications for 340B stakeholders, a federal district judge in Indianapolis today granted drug manufacturer Eli Lilly’s motion for a preliminary injunction stopping the U.S. Health and Human Services Department from implementing or enforcing regulations establishing the 340B drug pricing program’s new administrative dispute resolution.

Judge Sarah Evans Barker’s March 16 order is a major victory for Lilly, which last summer was the first drug maker to deny 340B pricing on its products when they are dispensed by covered entities’ contract pharmacies. Several other manufacturers have followed suit, either denying 340B pricing on drugs dispensed to contract pharmacies or conditioning such pricing on entities’ provision of 340B contract pharmacy claims data.

In a decision that could have significant implications for 340B stakeholders, a federal district judge in Indianapolis today granted drug manufacturer Eli Lilly’s motion for a preliminary injunction stopping the U.S. Health and Human Services Department from implementing or enforcing regulations establishing the 340B drug pricing program’s new administrative dispute resolution.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report